Dividend Contenders List: Top 15

11. Bristol-Myers Squibb Company (NYSE:BMY)

Dividend Yield as of November 11: 3.97%

Bristol-Myers Squibb Company (NYSE:BMY) is a New York-based multinational pharmaceutical company. It has traditionally concentrated on treatments for hematology, oncology, immunology, and cardiovascular conditions. In the third quarter, the company made significant progress, highlighted by the landmark US approval of Cobenfy for schizophrenia, ongoing sales growth, robust cash flow generation, and key advancements in its pipeline. The stock has surged by over 14.5% since the start of 2024.

Bristol-Myers Squibb Company (NYSE:BMY) generated $11.9 billion in revenues in the third quarter of 2024, which showed an 8.5% growth from the same period last year. The strong performance in the quarter was fueled by sales growth across its expanded oncology portfolio and effective operational execution. Overall, the results showcased the company’s capability to overcome competitive challenges while driving substantial revenue growth. At the end of the quarter, it had roughly $8 billion available in cash and cash equivalents.

Bristol-Myers Squibb Company (NYSE:BMY) is focused on finishing the year with strong execution, advancing its Growth Portfolio, prioritizing high-growth opportunities, and continuing to achieve transformational results for patients. Worldwide revenues for the Growth Portfolio rose to $5.8 billion in the most recent quarter, up from $4.9 billion in the same period last year, reflecting an 18% increase on a reported basis or 20% when adjusted for foreign exchange effects.

Bristol-Myers Squibb Company (NYSE:BMY), one of the best stocks on our dividend contenders list, currently offers a quarterly dividend of $0.60 per share. The company has been growing its dividends for 18 consecutive years. The stock’s dividend yield on November 11 came in at 3.9%.